Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CELZ
CELZ
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CELZ News
Creative Medical Technology Holdings Shares Surge 78% Following Warrant Exercise Agreement
Jul 01 2026
NASDAQ.COM
Creative Medical Technology Holdings Announces Stock Warrant Exercise
Jun 30 2026
Newsfilter
Creative Medical Technology Announces Public Offering of 3.05 Million Shares
Jun 26 2026
stocktwits
CELZ Receives FDA Clearance to Expand ADAPT Clinical Trial
Jun 23 2026
NASDAQ.COM
Creative Medical Receives FDA Clearance for Expanded Clinical Trial
Jun 22 2026
Newsfilter
CELZ Biodefense Platform Approved for Expansion
Jun 16 2026
Newsfilter
Creative Medical Achieves Second International Nonproprietary Name Milestone
Feb 10 2026
Newsfilter
Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes
Jan 16 2026
NASDAQ.COM
Creative Medical Technologies Reports Positive CELZ-201 Interim Data, Significant Pain Relief Achieved
Jan 13 2026
NASDAQ.COM
Creative Medical Reports Positive Interim Data for CELZ-201 in Chronic Back Pain Trial
Jan 13 2026
Globenewswire
Creative Medical Receives Approval to Advance Veterans' Burn Pit Initiative
Jan 06 2026
Globenewswire
Creative Medical Completes Enrollment for ADAPT Trial on Chronic Lower Back Pain
Dec 18 2025
NASDAQ.COM
Creative Medical Completes Patient Enrollment in CELZ-201 Clinical Trial
Dec 17 2025
Newsfilter
Creative Medical Completes Patient Enrollment in CELZ-201 Clinical Trial for Chronic Back Pain
Dec 17 2025
Globenewswire
Creative Medical Secures WHO Approval for Olastrocel, Enhancing Global Development Prospects
Dec 02 2025
Newsfilter
Creative Medical Secures WHO Approval for Olastrocel Name, Enhancing Global Development
Dec 02 2025
Globenewswire
Show More News
